Loading clinical trials...
Loading clinical trials...
Phase II Study of TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab "Boost Concomitant" With Cetuximab in Patients With Local Advanced Larynx/Hypolarynx Carcinoma
Conditions
Interventions
Docetaxel+Cisplatin+5-FU+ Radiotherapy+Cetuximab
Locations
4
Spain
Hospital Carlos Haya
Málaga, Andalusia, Spain
Fundación Jiménez Díaz
Madrid, Madrid, Spain
Clinica Universitaria de Navarra
Pamplona, Navarre, Spain
Hospital de Navarra
Pamplona, Navarre, Spain
Start Date
May 1, 2009
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
September 29, 2011
Lead Sponsor
Fundacion Miguel Servet
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions